In an exclusive interview with The Animal Economics during UBEK 2025, Embion founder Georgios Savoglidis highlighted the urgency of developing natural alternatives to antibiotics in poultry production. At the heart of Embion’s approach is PREMBION, which he described as a “key product” in promoting health and sustainability in the sector.
“We know the Turkish poultry industry is highly dynamic,” said Savoglidis. “We’re proud to be part of this ecosystem and contribute with natural, health-focused solutions.”
PREMBION stands out as an intelligent biotic developed using malted barley grains. Its core strength lies in beta defensins—natural peptides that are part of the immune system. These peptides help stabilize microbial populations in the gut, enhancing digestion and animal growth.
“PREMBION is designed to optimize intestinal balance and boost performance,” Savoglidis explained. “It’s especially effective in defending animals from stressors and maintaining gut health without resorting to antibiotics.”
Beta defensins disrupt microbial membrane integrity, interfere with metabolism and replication, and are activated in response to infections, inflammation, or injury—making them a strategic tool in reducing antibiotic reliance.
As antibiotic resistance rises globally, PREMBION offers a cutting-edge, health-driven solution for the poultry industry that aligns with both performance goals and sustainability demands.
More information on the product is available at embiontech.com.
👉Watch the full interview on The Animal Economics official YouTube channel.
All rights reserved to The Animal Economics © Copyright 2026 | Web design & implementation: PAQ Consultancy
This website uses cookies. For details, please see our privacy policy. By clicking on the relevant button or any other element of the page, you consent to the use of cookies.